VA Providence dermatologist to co-chair $34M skin cancer drug study

PROVIDENCE – A nationwide trial co-chaired by a VA Providence Healthcare System dermatologist has been awarded $34 million from the VA Cooperative Studies Program. The six-year trial aims to measure the effectiveness of imiquimod, a topical medication, as a treatment for basal cell carcinoma, a common type of skin cancer. Dr. Martin A. Weinstock, chief…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now